The USFDA approval makes SII - the first Indian vaccine maker to export vaccines to the US market, a testimony to the company's abilities t...

The vaccine maker on Monday had said its COVID-19 vaccine was more than 90 per cent effective in a large, late-stage US-based clinical tria...

The biotech firm said in March its shot could get cleared by the Food and Drug Administration for emergency use as early as May.